Fundamentals and Applications of Controlled Release Drug Delivery

The Need for Drugs and Drug Delivery Systems.- Overview of Controlled Release Mechanisms.- Hydrophobic Polymers of Pharmaceutical Significance.- Hydrogels.- Biodegradable Polymers in Drug Delivery Systems.- Diffusion Controlled Drug Delivery Systems.- Swelling Controlled Drug Delivery Systems.- Degradable Polymeric Carriers for Parenteral Controlled Drug Delivery Systems.- Porous Systems.- Targeted Delivery Using Biodegradable polymeric Nanoparticles.- Liposomes in Drug Delivery.- Receptor Mediated Delivery Systems for Cancer Therapeutics.- Biological Rhythms, Drug Delivery, and Chronotherapeutics.- Site Specific Controlled Release for Cardiovascular Disease - Translational Direction.- Drug Delivery Systems to Fight Cancer.- Applications of Vaccine Delivery in Infectious Diseases.- Tissue Engineering in Drug Delivery.- The Shaping of Controlled Release Drug Product Development by Emerging Trends in the Commercial, Regulatory and Political Macro-Environment

[1]  Theresa M Allen,et al.  Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. , 2002, Cancer research.

[2]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[3]  K. Shakesheff,et al.  Synthesis and Characterisation of a Degradable Poly(lactic acid)−Poly(ethylene glycol) Copolymer with Biotinylated End Groups , 2001 .

[4]  Darrell M. Wilson,et al.  A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator , 2009, Journal of diabetes science and technology.

[5]  Mansoor Amiji,et al.  Epidermal Growth Factor Receptor-Targeted Gelatin-Based Engineered Nanocarriers for DNA Delivery and Transfection in Human Pancreatic Cancer Cells , 2008, The AAPS Journal.

[6]  J. Hadgraft,et al.  Modified-Release Drug Delivery Technology , 2002 .

[7]  Joseph Kost,et al.  Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[8]  C. Butts,et al.  L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer , 2007, Clinical Cancer Research.

[9]  X. Banquy,et al.  Selectins ligand decorated drug carriers for activated endothelial cell targeting. , 2008, Bioconjugate chemistry.

[10]  V. Lenaerts,et al.  Degradation of poly (isobutyl cyanoacrylate) nanoparticles. , 1984, Biomaterials.

[11]  C. Passirani,et al.  Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. , 1998, Life sciences.

[12]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[13]  Y. Kawashima,et al.  Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes , 1996, Pharmaceutical Research.

[14]  V. Torchilin.  Liposomes as delivery agents for medical imaging. , 1996, Molecular medicine today.

[15]  Yan Zhang,et al.  Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Jayanth Panyam,et al.  Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. , 2009, Biomaterials.

[17]  Stavroula Sofou,et al.  Antibody-targeted liposomes in cancer therapy and imaging , 2008, Expert opinion on drug delivery.

[18]  P Couvreur,et al.  Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.

[19]  Y. Kawashima,et al.  Mucoadhesive nanoparticulate systems for peptide drug delivery. , 2001, Advanced drug delivery reviews.

[20]  Vladimir P. Torchilin,et al.  ATP-Loaded Liposomes Effectively Protect the Myocardium in Rabbits with an Acute Experimental Myocardial Infarction , 2005, Pharmaceutical Research.

[21]  A. Hall,et al.  Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. , 1998, Science.

[22]  Qiang Zhang,et al.  Phospholipid deformable vesicles for buccal delivery of insulin. , 2002, Chemical & pharmaceutical bulletin.

[23]  T. Park,et al.  In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles , 2005, Journal of biomaterials science. Polymer edition.

[24]  Jayanth Panyam,et al.  Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. , 2006, Journal of nanoscience and nanotechnology.

[25]  H. Kolb,et al.  The growing impact of click chemistry on drug discovery. , 2003, Drug discovery today.

[26]  Y. Tseng,et al.  Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. , 2002, Molecular pharmacology.

[27]  Stavroula Sofou,et al.  Surface-active liposomes for targeted cancer therapy. , 2007, Nanomedicine.

[28]  J. Kreuter,et al.  Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[29]  Martyn C. Davies,et al.  Polystyrene-Poly (Ethylene Glycol) (PS-PEG2000) Particles as Model Systems for Site Specific Drug Delivery. 2. The Effect of PEG Surface Density on the in Vitro Cell Interaction and in VivoBiodistribution , 1994, Pharmaceutical Research.

[30]  R. Desnick,et al.  Enzyme therapy. VI: Comparative in vivo fates and effects on lysosomal integrity of enzyme entrapped in negatively and positively charged liposomes. , 1977, Biochimica et biophysica acta.

[31]  P. Couvreur,et al.  Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models , 2007, Journal of drug targeting.

[32]  M. Cotten,et al.  Transferrin-polycation conjugates as carriers for DNA uptake into cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Couvreur,et al.  Radical Emulsion Polymerization of Alkylcyanoacrylates Initiated by the Redox System Dextran-Cerium(IV) under Acidic Aqueous Conditions , 2003 .

[34]  D Barry Keenan,et al.  The pathway to the closed-loop artificial pancreas: research and commercial perspectives. , 2010, Pediatric endocrinology reviews : PER.

[35]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.

[36]  Z. Zhou,et al.  In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. , 2005, International journal of pharmaceutics.

[37]  Eun Seong Lee,et al.  In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. , 2009, Molecular pharmaceutics.

[38]  V. Torchilin,et al.  ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[39]  P. Couvreur,et al.  In vitro model for the degradation of alkylcyanoacrylate nanoparticles. , 1990, Biomaterials.

[40]  Rassoul Dinarvand,et al.  PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. , 2008, International journal of pharmaceutics.

[41]  P. Couvreur,et al.  Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis , 1991, Antimicrobial Agents and Chemotherapy.

[42]  P. Couvreur,et al.  Synthesis of Highly Functionalized Poly(alkyl cyanoacrylate) Nanoparticles by Means of Click Chemistry , 2008 .

[43]  V. Torchilin,et al.  siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene , 2006, Journal of Controlled Release.

[44]  Ying Sun,et al.  Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma , 2010, Journal of materials science. Materials in medicine.

[45]  Y. Schneider,et al.  PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[46]  S. Grinstein,et al.  CD44 is a phagocytic receptor. , 2006, Blood.

[47]  H. Nishide,et al.  Polymerized liposome as the carrier of heme. A physically stable oxygen carrier under physiological conditions. , 1985 .

[48]  V. Pillay,et al.  Drug delivery technologies for chronotherapeutic applications , 2009, Pharmaceutical development and technology.

[49]  R. Bankert,et al.  Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice. , 2000, Cancer research.

[50]  K. Polonsky,et al.  In vivo pulsatility of pancreatic islet peptides. , 1986, The American journal of physiology.

[51]  Josep Vehí,et al.  Combining Basal-Bolus Insulin Infusion for Tight Postprandial Glucose Control: An in Silico Evaluation in Adults, Children, and Adolescents , 2010, Journal of diabetes science and technology.

[52]  R. Hermida,et al.  Administration Time–Dependent Influence of Aspirin on Blood Pressure in Pregnant Women , 2003, Hypertension.

[53]  E. Jubeli,et al.  Synthesis, characterization, and molecular recognition of sugar‐functionalized nanoparticles prepared by a combination of ROP, ATRP, and click chemistry , 2010 .

[54]  Hongzhe Sun,et al.  Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.

[55]  V. Torchilin,et al.  Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  A. Rawat,et al.  Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles , 2006, Journal of drug targeting.

[57]  G. Storm,et al.  Immunoliposomes as Enzyme-Carriers (Immuno-Enzymosomes) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT): Optimization of Prodrug Activating Capacity , 1996, Pharmaceutical Research.

[58]  A. Sabnis,et al.  Shear-regulated uptake of nanoparticles by endothelial cells and development of endothelial-targeting nanoparticles. , 2009, Journal of biomedical materials research. Part A.

[59]  C. Allen,et al.  Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. , 2006, Bioconjugate chemistry.

[60]  Adenosine triphosphate liposomes: encapsulation and distribution studies. , 1990, Pharmaceutical research.

[61]  W. Waldhäusl,et al.  Efficacy of Pulsatile Versus Continuous Insulin Administration on Hepatic Glucose Production and Glucose Utilization in Type I Diabetic Humans , 1986, Diabetes.

[62]  V. Torchilin.  Surface-modified liposomes in gamma- and MR-imaging , 1997 .

[63]  Q. Shi,et al.  Characterization of folate-chitosan-DNA nanoparticles for gene therapy. , 2006, Biomaterials.

[64]  M. Woodle,et al.  Long Circulating Liposomes: Old Drugs, New Therapeutics , 1998, Biotechnology Intelligence Unit.

[65]  J. Hanes,et al.  Polymeric particles conjugated with a ligand to VCAM‐1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis , 2008, Biotechnology and bioengineering.

[66]  T. Reynolds,et al.  Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[67]  E. Haus.  Chronobiology of Circulating Blood Cells and Platelets , 1992 .

[68]  Hyun-chul Lee,et al.  Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. , 2005, International journal of pharmaceutics.

[69]  M. Davies,et al.  The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process , 1989 .

[70]  R. Schiffelers,et al.  Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[71]  J. Rothbard,et al.  Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. , 2004, Journal of the American Chemical Society.

[72]  S. Davis,et al.  The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. , 2001, Biochimica et biophysica acta.

[73]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[74]  M. Brandl,et al.  Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes. , 1997, Investigative radiology.

[75]  M. El-Samaligy,et al.  Polyalkyl cyanoacrylate nanocapsules , 1986, The Journal of pharmacy and pharmacology.

[76]  Zhirong Zhang,et al.  Preparation and Characterization of a Novel Nonviral Gene Transfer System: Procationic-Liposome-Protamine-DNA Complexes , 2007, Drug delivery.

[77]  P. Mallmann,et al.  Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer , 2000, Anti-cancer drugs.

[78]  Ching-Li Tseng,et al.  The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. , 2009, Biomaterials.

[79]  Dae-Duk Kim,et al.  Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[80]  Werner Tjarks,et al.  A novel pH-sensitive liposome formulation containing oleyl alcohol. , 2002, Biochimica et biophysica acta.

[81]  D. Tzemach,et al.  Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes , 1999, Cancer.

[82]  Sérgio Simões,et al.  On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.

[83]  Nikhil Biswas,et al.  Drug delivery system based on chronobiology--A review. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[84]  G. Betageri,et al.  Transdermal iontophoretic delivery of enkephalin formulated in liposomes. , 1996, Journal of pharmaceutical sciences.

[85]  R. Gurny,et al.  Aqueous nanodispersions prepared by a salting-out process , 1992 .

[86]  N. Chiaramoni,et al.  Stability of Liposomal Formulations in Physiological Conditions for Oral Drug Delivery , 2004, Drug delivery.

[87]  M. Shoichet,et al.  Doxorubicin‐Conjugated Immuno‐Nanoparticles for Intracellular Anticancer Drug Delivery , 2009 .

[88]  M. Woodle,et al.  Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.

[89]  E. Schacht,et al.  In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. , 1998, Journal of pharmaceutical sciences.

[90]  K. Velonia,et al.  Click Chemistry: A Powerful Tool to Create Polymer‐Based Macromolecular Chimeras , 2008 .

[91]  G. Paolisso,et al.  Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. , 1991, The Journal of clinical endocrinology and metabolism.

[92]  Y. Kawashima,et al.  Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[93]  Lawrence Mayer,et al.  In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. , 2009, Leukemia research.

[94]  R. Hintsche,et al.  Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin , 2006, IEEE Transactions on Information Technology in Biomedicine.

[95]  Xian‐Zheng Zhang,et al.  Functionalized amphiphilic hyperbranched polymers for targeted drug delivery. , 2008, Biomacromolecules.

[96]  V. Torchilin.  Antibody-modified liposomes for cancer chemotherapy. , 2008, Expert Opinion on Drug Delivery.

[97]  N. Konvalina,et al.  Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes. , 2011, Diabetes research and clinical practice.

[98]  T. Allen,et al.  Improved Outcome When B-Cell Lymphoma Is Treated with Combinations of Immunoliposomal Anticancer Drugs Targeted to Both the CD19 and CD20 Epitopes , 2004, Clinical Cancer Research.

[99]  R. Debs,et al.  Cationic liposome-mediated gene delivery in vivo. , 2003, Methods in enzymology.

[100]  Vladimir P Torchilin,et al.  Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. , 2008, Advanced drug delivery reviews.

[101]  S. L. Bridal,et al.  The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. , 2010, Biomaterials.

[102]  T. Ravikumar,et al.  Specific active immunotherapy with butanol-extracted, tumor-associated antigens incorporated into liposomes. , 1984, Surgery.

[103]  Vladimir P Torchilin,et al.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[104]  J. Poupaert,et al.  Development of poly (dialkyl methylidenemalonate) nanoparticles as drug carriers , 1993 .

[105]  Wei-Chiang Shen,et al.  Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives , 2007, Pharmaceutical Research.

[106]  J. Nicolas,et al.  Recent advances in the design of bioconjugates from controlled/living radical polymerization , 2010 .

[107]  P. Speiser,et al.  Nanoparticles--a new colloidal drug delivery system. , 1978, Pharmaceutica acta Helvetiae.

[108]  F. Chang,et al.  Sterically stabilized anti‐idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B‐cell lymphoma model , 1999, International journal of cancer.

[109]  G. Halbert,et al.  The in Vitro Cell Association of Invasin Coated Polylactide-Co-glycolide Nanoparticles , 2000, Pharmaceutical Research.

[110]  Elias Fattal,et al.  Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. , 2007, International journal of pharmaceutics.

[111]  R. Gurny,et al.  Biodegradable nanoparticles for direct or two-step tumor immunotargeting. , 2006, Bioconjugate chemistry.

[112]  P. Couvreur,et al.  Design of folic acid-conjugated nanoparticles for drug targeting. , 2000, Journal of pharmaceutical sciences.

[113]  E. Estey,et al.  Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series , 2006, Leukemia & lymphoma.

[114]  Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors. , 2001, Life sciences.

[115]  D. Sørensen,et al.  Cationic liposome-mediated delivery of siRNAs in adult mice. , 2003, Biochemical and biophysical research communications.

[116]  Douglas J. Goetz,et al.  Ligand Coated Nanosphere Adhesion to E- and P-Selectin under Static and Flow Conditions , 2001, Annals of Biomedical Engineering.

[117]  Eun Seong Lee,et al.  Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. , 2008, Small.

[118]  Robert Langer,et al.  Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles , 2008, Proceedings of the National Academy of Sciences.

[119]  Ming-Jium Shieh,et al.  Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer. , 2008, Biomaterials.

[120]  M. Wilchek,et al.  Introduction to avidin-biotin technology. , 1990, Methods in enzymology.

[121]  Hatem Fessi,et al.  Preparation and Characterization of Nanocapsules from Preformed Polymers by a New Process Based on Emulsification-Diffusion Technique , 1998, Pharmaceutical Research.

[122]  Babich,et al.  Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool. , 2000, Colloids and surfaces. B, Biointerfaces.

[123]  Yoshioka Toshio,et al.  Specific delivery of mitomycin c to the liver, spleen and lung: Nano- and m1crospherical carriers of gelatin , 1981 .

[124]  Daniel A Hammer,et al.  Quantifying nanoparticle adhesion mediated by specific molecular interactions. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[125]  W. Chui,et al.  Design of a Multifunctional PLGA Nanoparticulate Drug Delivery System: Evaluation of its Physicochemical Properties and Anticancer Activity to Malignant Cancer Cells , 2009, Pharmaceutical Research.

[126]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[127]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[128]  Stanley J. Vernier,et al.  Evaluating the Automated Blood Glucose Pattern Detection and Case-Retrieval Modules of the 4 Diabetes Support System® , 2010, Journal of diabetes science and technology.

[129]  Nicholas A Peppas,et al.  Stimuli-sensitive hydrogels: ideal carriers for chronobiology and chronotherapy , 2004, Journal of biomaterials science. Polymer edition.

[130]  A. Mucci,et al.  DOTAP/UDCA vesicles: novel approach in oligonucleotide delivery. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[131]  M. G. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions , 2001 .

[132]  P. Couvreur,et al.  Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules. , 1986, Journal of pharmaceutical sciences.

[133]  Y. Kato,et al.  Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[134]  R. Gurny,et al.  New approach for the preparation of nanoparticles by an emulsification-diffusion method , 1995 .

[135]  S. Antimisiaris,et al.  Liposomes for drug delivery to the lungs by nebulization. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[136]  A. Kabanov,et al.  Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. , 1999, Bioconjugate chemistry.

[137]  Sung‐Wook Choi,et al.  Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[138]  V. Torchilin,et al.  Protective Effect of Coenzyme Q10-loaded Liposomes on the Myocardium in Rabbits with an Acute Experimental Myocardial Infarction , 2007, Pharmaceutical Research.

[139]  Q. Ping,et al.  Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. , 2004, Acta pharmacologica Sinica.

[140]  H. Horinouchi,et al.  Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats* , 2004, Critical care medicine.

[141]  V. Torchilin,et al.  p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. , 2001, Biochimica et biophysica acta.

[142]  B. Smide,et al.  Clarifying responsibility for self-management of diabetes in adolescents using insulin pumps--a qualitative study. , 2011, Journal of advanced nursing.

[143]  R. Margalit,et al.  Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. , 1994, Archives of biochemistry and biophysics.

[144]  Robert Gurny,et al.  Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[145]  Elias Fattal,et al.  Polyisobutylcyanoacrylate Nanocapsules Containing an Aqueous Core as a Novel Colloidal Carrier for the Delivery of Oligonucleotides , 2000, Pharmaceutical Research.

[146]  R. Gurny,et al.  Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size , 1992 .

[147]  David A Jaffray,et al.  Multimodal Contrast Agent for Combined Computed Tomography and Magnetic Resonance Imaging Applications , 2006, Investigative radiology.

[148]  D. Begley,et al.  Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[149]  V. Lenaerts,et al.  New method for the preparation of cyanoacrylic nanoparticles with improved colloidal properties. , 1989, Journal of pharmaceutical sciences.

[150]  David A. Jaffray,et al.  In Vivo Performance of a Liposomal Vascular Contrast Agent for CT and MR-Based Image Guidance Applications , 2007, Pharmaceutical Research.

[151]  Dae-Duk Kim,et al.  Liposome Formulation of Paclitaxel with Enhanced Solubility and Stability , 2007, Drug delivery.

[152]  M A Vandelli,et al.  Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[153]  M. Gnant,et al.  Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma , 2001, British Journal of Cancer.

[154]  Jean-François Lutz,et al.  1,3-dipolar cycloadditions of azides and alkynes: a universal ligation tool in polymer and materials science. , 2007, Angewandte Chemie.

[155]  Tae Gwan Park,et al.  Folate receptor targeted biodegradable polymeric doxorubicin micelles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[156]  Zhiyuan Hu,et al.  Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery. , 2008, Journal of biomedical materials research. Part A.

[157]  Hua Ai,et al.  cRGD-functionalized polymer micelles for targeted doxorubicin delivery. , 2004, Angewandte Chemie.

[158]  M. Trudel,et al.  Virosome preparation: differences between influenza and rubella hemagglutinin adsorption. , 1981, Canadian journal of microbiology.

[159]  Philip S Low,et al.  Folate receptor-mediated drug targeting: from therapeutics to diagnostics. , 2005, Journal of pharmaceutical sciences.

[160]  A. Atkinson,et al.  Comparison of the priming effects of pulsatile and continuous insulin delivery on insulin action in man. , 2003, Metabolism: clinical and experimental.

[161]  M. Berger,et al.  Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[162]  Joseph D. Andrade,et al.  Protein—surface interactions in the presence of polyethylene oxide , 1991 .

[163]  V. Torchilin.  Polymeric contrast agents for medical imaging. , 2000, Current pharmaceutical biotechnology.

[164]  Patrick Couvreur,et al.  Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. , 2005, Bioconjugate chemistry.

[165]  P. Couvreur,et al.  Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting , 1999 .

[166]  C. Remuñán-López,et al.  Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles , 1999, Pharmaceutical Research.

[167]  H. J. Baker,et al.  Enzyme replacement using liposome carriers in feline GM1 gangliosidosis fibroblasts , 1978, Nature.

[168]  M. Peracchia.  Stealth nanoparticles for intravenous administration , 2003 .

[169]  E. K. Park,et al.  Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[170]  E. Shusta,et al.  Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation , 2007, Pharmaceutical Research.

[171]  V. Torchilin,et al.  TAT-liposomes: a novel intracellular drug carrier. , 2003, Current protein & peptide science.

[172]  M. Nango,et al.  Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[173]  E. Fattal,et al.  Quantification of pegylated phospholipids decorating polymeric microcapsules of perfluorooctyl bromide by reverse phase HPLC with a charged aerosol detector. , 2008, Journal of pharmaceutical and biomedical analysis.

[174]  Jie Pan,et al.  Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. , 2008, Biomaterials.

[175]  Lie Ma,et al.  Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and Folic acid binding to achieve selective cell targeting. , 2010, Journal of colloid and interface science.

[176]  Jörg Huwyler,et al.  Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney. , 2005, Journal of the American Society of Nephrology : JASN.

[177]  Robert Langer,et al.  Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. , 2007, Biomaterials.

[178]  J. Benoit,et al.  Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[179]  P Couvreur,et al.  Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. , 1999, Biomaterials.

[180]  F. Szoka,et al.  Comparative properties and methods of preparation of lipid vesicles (liposomes). , 1980, Annual review of biophysics and bioengineering.

[181]  E Fattal,et al.  Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[182]  S. Ohdo,et al.  Molecular basis of chronopharmaceutics. , 2011, Journal of pharmaceutical sciences.

[183]  Yuhan Lee,et al.  Oil-encapsulating PEO-PPO-PEO/PEG shell cross-linked nanocapsules for target-specific delivery of paclitaxel. , 2007, Biomacromolecules.

[184]  R. Gurny,et al.  Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[185]  V. Torchilin,et al.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[186]  D. Bazile,et al.  Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.

[187]  R. Müller,et al.  Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. , 2005, Biomaterials.

[188]  G. Tosi,et al.  Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[189]  V. Torchilin,et al.  "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. , 2006, Bioconjugate chemistry.

[190]  T. K. Natarajan,et al.  Albumin microspheres for study of the reticuloendothelial system. , 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[191]  Janko Kos,et al.  Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[192]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[193]  M Rabinovitch,et al.  Professional and non-professional phagocytes: an introduction. , 1995, Trends in cell biology.

[194]  You Han Bae,et al.  Polymeric micelle for tumor pH and folate-mediated targeting. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[195]  T. Young,et al.  Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. , 2007, Biomaterials.

[196]  J. Mastrototaro,et al.  The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. , 2008, Diabetes technology & therapeutics.

[197]  R. Schiffelers,et al.  Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.

[198]  J. Kreuter,et al.  In vitro studies of poly(methyl methacrylate) adjuvants. , 1976, Journal of pharmaceutical sciences.

[199]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[200]  Johannes D Veldhuis,et al.  Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. , 2005, Diabetes.

[201]  Y. M. Lee,et al.  Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. , 2001, Biomaterials.

[202]  Robert Langer,et al.  Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.

[203]  Christine Allen,et al.  In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels , 2010, Pharmaceutical Research.

[204]  A. Fahr,et al.  Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[205]  E. C. van Winden.  Freeze-drying of liposomes: theory and practice. , 2003, Methods in enzymology.

[206]  H. Wagner,et al.  Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation. , 1970, The International journal of applied radiation and isotopes.

[207]  P. Couvreur,et al.  Preparation and Characterization of Novel Poly(methylidene Malonate 2.1.2.)-Made Nanoparticles , 1994, Pharmaceutical Research.

[208]  P. Couvreur,et al.  Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties , 1979, The Journal of pharmacy and pharmacology.

[209]  Gert Storm,et al.  Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .

[210]  Jinming Gao,et al.  Folate-functionalized polymeric micelles for tumor targeted delivery of a potent multidrug-resistance modulator FG020326. , 2008, Journal of biomedical materials research. Part A.

[211]  Jeong Won Lee,et al.  Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles , 2010, Clinical Cancer Research.

[212]  P. Couvreur,et al.  Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. , 1993, Journal of biomedical materials research.

[213]  Robert J. Lee,et al.  Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy. , 2003, Anticancer research.

[214]  J Szebeni,et al.  Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. , 1999, Circulation.

[215]  Q. Ping,et al.  Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. , 2008, International journal of pharmaceutics.

[216]  M. Michaelis,et al.  Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.

[217]  P. Couvreur,et al.  Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity. , 1991, Journal of microencapsulation.

[218]  H. Hauser,et al.  Encapsulation of hemoglobin in phospholipid liposomes: characterization and stability. , 1985, Biochemistry.

[219]  S. Lesieur,et al.  Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation. , 2007, International journal of pharmaceutics.

[220]  R. Turner,et al.  Pulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery , 1983, Diabetes.

[221]  P. Artursson,et al.  Characterization of polyacryl starch microparticles as carriers for proteins and drugs. , 1984, Journal of pharmaceutical sciences.

[222]  C. Berkland,et al.  ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[223]  G. Paolisso,et al.  Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications , 1987, Diabetologia.

[224]  Na Zhang,et al.  PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. , 2008, Bioconjugate chemistry.

[225]  S. Sahoo,et al.  Efficacy of transferrin‐conjugated paclitaxel‐loaded nanoparticles in a murine model of prostate cancer , 2004, International journal of cancer.

[226]  S. Wagner,et al.  Preparation and Evaluation of Lyophilized Iopromide‐Carrying Liposomes for Liver Tumor Detection , 1993, Investigative radiology.

[227]  S. Krähenbühl,et al.  Targeting of daunomycin using biotinylated immunoliposomes: Pharmacokinetics, tissue distribution and in vitro pharmacological effects , 2005, Journal of drug targeting.

[228]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[229]  R. Gurny,et al.  An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. , 1995, Life sciences.

[230]  S. Sundar,et al.  Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[231]  Z. Gu,et al.  Synthesis, characterization and transfection of a novel folate-targeted multipolymeric nanoparticles for gene delivery , 2009, Journal of materials science. Materials in medicine.

[232]  M. Madou,et al.  Artificial Muscle Material with Fast Electroactuation under Neutral pH Conditions , 2004 .

[233]  B. Engelhardt,et al.  Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. , 2000, The Journal of pharmacology and experimental therapeutics.

[234]  R. Lai,et al.  The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. , 2010, Biomaterials.

[235]  S. Benita,et al.  Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[236]  L R Coney,et al.  Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.

[237]  K. Strebhardt,et al.  Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation. , 2008, Biomaterials.

[238]  K. Ulbrich,et al.  POLY(HPMA)-COATED LIPOSOMES DEMONSTRATE PROLONGED CIRCULATION IN MICE , 2001, Journal of liposome research.

[239]  Wei Lu,et al.  Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[240]  Sanyog Jain,et al.  Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. , 2004, International journal of pharmaceutics.

[241]  S. Sahoo,et al.  Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. , 2005, Molecular pharmaceutics.

[242]  M. Ogris,et al.  Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. , 2003, International journal of pharmaceutics.

[243]  P. Rutland,et al.  Diurnal variation in the effects of insulin on blood glucose, plasma non-esterified fatty acids and growth hormone , 2004, Diabetologia.

[244]  R. Rizza,et al.  Differences Between Prebreakfast and Late Afternoon Glycemic Responses to Exercise in IDDM Patients , 1990, Diabetes Care.

[245]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[246]  C. Alving,et al.  Complement-mediated acute effects of liposome-encapsulated hemoglobin. , 1999, Artificial cells, blood substitutes, and immobilization biotechnology.

[247]  R. Hill,et al.  Reconstitution of a porcine submaxillary gland beta-D-galactoside alpha 2----3 sialyltransferase into liposomes. , 1985, The Journal of biological chemistry.

[248]  S. Kawakami,et al.  Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. , 2007, Biomaterials.

[249]  Tae Gwan Park,et al.  Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[250]  Kyung Chul Cho,et al.  Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[251]  V. Labhasetwar,et al.  Biodegradable nanoparticles for cytosolic delivery of therapeutics. , 2007, Advanced drug delivery reviews.

[252]  Francisco Orallo,et al.  Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol , 2004, Pharmaceutical Research.

[253]  I. Sjöholm,et al.  Immobilization of proteins in microspheres of biodegradable polyacryldextran. , 1980, Journal of pharmaceutical sciences.

[254]  Y. Eto,et al.  Enzyme replacement with liposomes containing beta-galactosidase from Charonia lumpas in murine globoid cell leukodystrophy (twitcher). , 1985, Biochemical and biophysical research communications.

[255]  J. Kreuter,et al.  Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[256]  M. Zajac-Kaye,et al.  DNAase I encapsulated in liposomes can induce neoplastic transformation of syrian hamster embryo cells in culture , 1984, Cell.

[257]  Aliasger K Salem,et al.  Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[258]  H. Uludaǧ,et al.  Multifunctional Polymeric Micelles for Enhanced Intracellular Delivery of Doxorubicin to Metastatic Cancer Cells , 2008, Pharmaceutical Research.

[259]  S. C. Baer,et al.  Phagocytosis by zippers and triggers. , 1995, Trends in cell biology.

[260]  R.S. Parker,et al.  A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.

[261]  G. Wood,et al.  Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction , 2007, Biotechnology and bioengineering.

[262]  D. Cavadore,et al.  Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes , 1977, Diabetologia.

[263]  Rajiv V Shah,et al.  Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database. , 2010, Pediatric endocrinology reviews : PER.

[264]  K. Skubitz.  Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma* , 2003, Cancer investigation.

[265]  M. Prabaharan,et al.  Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. , 2009, Biomaterials.

[266]  A. Harken,et al.  Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation. , 1999, Circulation Research.

[267]  Donald S. Coffey,et al.  Identification and Characterization of Nuclease-stabilized RNA Molecules That Bind Human Prostate Cancer Cells via the Prostate-specific Membrane Antigen 1 , 2002 .

[268]  V. Torchilin,et al.  ATP-loaded immunoliposomes specific for cardiac myosin provide improved protection of the mechanical functions of myocardium from global ischemia in an isolated rat heart model , 2006, Journal of drug targeting.

[269]  H. Uludaǧ,et al.  Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. , 2007, Biomacromolecules.

[270]  John Walsh,et al.  Guidelines for Insulin Dosing in Continuous Subcutaneous Insulin Infusion Using New Formulas from a Retrospective Study of Individuals with Optimal Glucose Levels , 2010, Journal of diabetes science and technology.

[271]  Lin‐Yue Lanry Yung,et al.  Selectivity of folate conjugated polymer micelles against different tumor cells. , 2008, International journal of pharmaceutics.

[272]  R. Müller,et al.  Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. , 2006, Biomaterials.

[273]  G. Khuller,et al.  The protective efficacy of a liposomal encapsulated 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra tuberculosis in mice , 1997, Immunology and cell biology.

[274]  R. Gurny,et al.  Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles. , 2007, International journal of pharmaceutics.

[275]  Christine Jérôme,et al.  Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[276]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[277]  C. Miller,et al.  Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. , 1998, Biochemistry.

[278]  D. Bazile,et al.  Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. , 1996, Biomaterials.

[279]  V. Torchilin.  Liposomes as targetable drug carriers. , 1985, Critical reviews in therapeutic drug carrier systems.

[280]  Jie Pan,et al.  Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)- loaded nanoparticles of biodegradable polymers. , 2009, Biomaterials.

[281]  Qiang Zhang,et al.  RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells , 2009, Journal of drug targeting.

[282]  G. Schreiber,et al.  Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[283]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[284]  Robert Sachsenhofer,et al.  ′Click′ Chemistry in Polymer and Materials Science , 2007 .

[285]  Robert Langer,et al.  Nanoparticle–aptamer bioconjugates for cancer targeting , 2006, Expert opinion on drug delivery.

[286]  Jean-Pierre Benoit,et al.  Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.

[287]  Xiaoling Zhang,et al.  Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[288]  D. B. Keenan,et al.  Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm , 2010, Journal of diabetes science and technology.

[289]  V. Torchilin,et al.  Which polymers can make nanoparticulate drug carriers long-circulating? , 1995 .

[290]  P. Hildgen,et al.  Functionalized nanospheres loaded with anti-angiogenic drugs: cellular uptake and angiosuppressive efficacy. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[291]  M. Brewster,et al.  Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621. , 2010, International journal of pharmaceutics.

[292]  K. Anderson,et al.  The potential of liposomes in oral drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.

[293]  G. Zuccotti,et al.  Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study. , 2011, Diabetes technology & therapeutics.

[294]  P. Couvreur,et al.  Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading , 1990 .

[295]  P. Rohdewald,et al.  Interfacial Polymerization, A Useful Method for the Preparation of Polymethylcyanoacrylate Nanoparticles , 1986 .

[296]  K. Pavey,et al.  SPR analysis of the total reduction of protein adsorption to surfaces coated with mixtures of long- and short-chain polyethylene oxide block copolymers. , 1999, Biomaterials.

[297]  Y. Chevalier,et al.  Mechanism of nanocapsules formation by the emulsion-diffusion process. , 2008, Journal of colloid and interface science.

[298]  D. Perrier,et al.  Analysis of albumin microsphere preparation , 1984 .

[299]  Fahima Dilnawaz,et al.  Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. , 2009, Biomaterials.

[300]  Bruce Buckingham,et al.  Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems. , 2010, Endocrinology and metabolism clinics of North America.

[301]  J. Bancroft,et al.  Perimenstrual Symptoms in Women with Diabetes Mellitus and the Relationship to Diabetic Control , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[302]  Chulhee Kim,et al.  Block Copolymer Micelles Conjugated with anti-EGFR Antibody for Targeted Delivery of Anticancer Drug , 2008 .

[303]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[304]  J. Richie,et al.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[305]  F. Behar-Cohen,et al.  Oligonucleotide-Polyethylenimine Complexes Targeting Retinal Cells: Structural Analysis and Application to Anti-TGFβ-2 Therapy , 2006, Pharmaceutical Research.

[306]  Y. Quinn,et al.  New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. , 1999, Bioconjugate chemistry.

[307]  H. Fessi,et al.  [An original procedure for preparing nanocapsules of polyalkylcyanoacrylates for interfacial polymerization]. , 1986, Pharmaceutica acta Helvetiae.

[308]  T. Tice,et al.  Preparation of injectable controlled-release microcapsules by a solvent-evaporation process , 1985 .

[309]  V. Torchilin,et al.  Liposomes : a practical approach , 2003 .

[310]  Si-Shen Feng,et al.  Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. , 2007, Biomaterials.

[311]  Hong-Zhuan Chen,et al.  In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[312]  R. Reilly,et al.  Apoptotic epidermal growth factor (EGF)-conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapy. , 2007, Molecular pharmaceutics.

[313]  P Couvreur,et al.  Development of a new drug carrier made from alginate. , 1993, Journal of pharmaceutical sciences.

[314]  S. Sahu,et al.  In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery , 2010, Journal of materials science. Materials in medicine.

[315]  A. Aderem,et al.  Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.

[316]  R. G. Anderson,et al.  The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway , 1990, The Journal of cell biology.

[317]  P. Legrand,et al.  Poly(D,L-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties. , 2000, Journal of pharmaceutical sciences.

[318]  U. Matulonis,et al.  A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer. , 2004, Gynecologic oncology.

[319]  T. Park,et al.  Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate. , 2005, Macromolecular bioscience.

[320]  P. Low,et al.  Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. , 2002, Biochimica et biophysica acta.

[321]  R. Müller,et al.  Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake. , 1992, Clinical nutrition.

[322]  P. Couvreur,et al.  PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases , 2001, Journal of Neuroscience Methods.

[323]  J. Poupaert,et al.  Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice. , 1991, Journal of pharmaceutical sciences.

[324]  Ruxandra Gref,et al.  Polysaccharide-decorated nanoparticles. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[325]  P. Artursson,et al.  Identification of Cell Adhesion Molecules in the Human Follicle-Associated Epithelium That Improve Nanoparticle Uptake into the Peyer's Patches , 2006, Journal of Pharmacology and Experimental Therapeutics.

[326]  J. Melnick,et al.  Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes , 1980, Infection and immunity.

[327]  S. Takeoka,et al.  Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. , 2000, Bioconjugate chemistry.

[328]  Sylvia Wagner,et al.  Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles. , 2008, Bioconjugate chemistry.

[329]  M. Cima,et al.  A controlled-release microchip , 1999, Nature.

[330]  H. Kantarjian,et al.  Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[331]  J. Benoit,et al.  Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. , 2006, Journal of biomedical materials research. Part A.

[332]  J H Senior,et al.  Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.

[333]  G. Storm,et al.  Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of anticancer prodrugs , 1997 .

[334]  M. Shoichet,et al.  Click chemistry functionalized polymeric nanoparticles target corneal epithelial cells through RGD-cell surface receptors. , 2009, Bioconjugate chemistry.

[335]  Gareth Griffiths,et al.  Lysosomal Enzyme Trafficking between Phagosomes, Endosomes, and Lysosomes in J774 Macrophages , 1998, The Journal of Biological Chemistry.

[336]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[337]  M. Dewhirst,et al.  In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery , 2004, Magnetic resonance in medicine.

[338]  K. Strebhardt,et al.  Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. , 2006, Biomaterials.

[339]  E. Chang,et al.  Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. , 2002, Molecular cancer therapeutics.

[340]  S. Kawakami,et al.  Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[341]  E. Caron,et al.  Molecular mechanisms of phagocytic uptake in mammalian cells , 2008, Cellular and Molecular Life Sciences.

[342]  G. Birrenbach,et al.  Polymerized micelles and their use as adjuvants in immunology. , 1976, Journal of pharmaceutical sciences.

[343]  N. Berman,et al.  A mathematical model of oscillatory insulin secretion. , 1993, The American journal of physiology.

[344]  D F P Larkin,et al.  Antibody targeted gene transfer to endothelium , 2003, The journal of gene medicine.